Anti-glaucoma agents-induced pseudodendritic keratitis presumed to be herpetic simplex keratitis: a clinical case series
Authors:
Open Access
- 2 November 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-10
Abstract
Anti-glaucoma agents-induced corneal toxicity may be misdiagnosed as herpetic simplex keratitis (HSK). In our study, nineteen glaucoma patients were presumed to have HSK before referral. Corneal lesions were classified into (I) linear pseudodendritic lesions formed by elevated opacified cells, (II) linear pseudodendritic lesions formed by grouped superficial punctate keratitis (SPK), (III) satellite full-thickness epithelial defects, (IV) satellite lesions formed by elevated opacified cells, and (V) geographic lesions formed by grouped SPK. We observed thirty-one events, with 15 in the lower and 16 in the central corneas. There were 21 (67.7%) type II, five (16.1%) type V, two (6.5%) of each for types III and IV, and one (3.2%) type I events. Among linear lesions (types I and II), 17 (77.3%) had horizontal and 5 (22.7%) had curvilinear orientations. Exposure duration to the last-added anti-glaucoma agent was three days to 14.5 years. About half of the events (16/31, 51.6%) used prostaglandin analogues, and 30/31 (96.8%) applied benzalkonium chloride (BAK)-containing agents. All lesions resolved within two months after decreasing offending medications or enhancing protection of ocular surface. In conclusion, anti-glaucoma agents-induced pseudodendritic keratitis presents majorly in central-lower cornea as horizontally linear lesions, and BAK-containing agents are observed in the most events.Keywords
Funding Information
- The Department of Medical Research National Taiwan University
- National Taiwan University Hospital Research Grant (108-A144)
This publication has 39 references indexed in Scilit:
- An In Vivo Confocal Microscopy Analysis of Effects of Topical Antiglaucoma Therapy With Preservative on Corneal Innervation and MorphologyAmerican Journal of Ophthalmology, 2009
- Comparison of Corneal and Conjunctival Changes After Dosing of Travoprost Preserved With sofZia, Latanoprost With 0.02% Benzalkonium Chloride, and Preservative-free Artificial TearsCornea, 2008
- The number of people with glaucoma worldwide in 2010 and 2020British Journal of Ophthalmology, 2006
- Pathogenesis, clinical features and management of recurrent corneal erosionsEye, 2005
- Intraocular Pressure–Lowering Effects of All Commonly Used Glaucoma DrugsOphthalmology, 2005
- The Multifocal ERG in Diabetic Patients without Retinopathy during Euglycemic ClampingInvestigative Ophthalmology & Visual Science, 2005
- HSV-1 DNA in Tears and Saliva of Normal AdultsInvestigative Ophthalmology & Visual Science, 2005
- Bilateral herpetic keratoconjunctivitisOphthalmology, 2003
- Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0.12% unoprostoneBritish Journal of Ophthalmology, 2000
- Pathogenesis and treatment of recurrent erosion.British Journal of Ophthalmology, 1985